TL12-186

Research use only, not for human use.

TL12-186 is a Cereblon-dependent kinase degrader that degrades CDK, BTK, FLT3, Aurora and other kinases.TL12-186 inhibits CDK2/cyclin A and CDK9/cyclin T1 with IC50s of 73 and 55 nM, respectively.

TL12-186 is a Cereblon-dependent multi-kinase PROTAC degrader. Multi-kinases include CDK, BTK, FLT3, Aurora kinases, TEC, ULK, ITK, et al. TL12-186 inhibits CDK2/cyclin A (IC50=73 nM) and CDK9/cyclin T1 (IC50=55 nM).

Cell Proliferation Assay Cell Line:WT and CRBN-/- MOLM-14 cells; WT and CRBN-/- MOLT-4 cells Concentration:1, 10, 100, 1000, 10000 nM Incubation Time:2 days Result:Exhibited a CRBN-dependent pharmacological effect, displaying 13 to 15-fold more potent inhibition of survival of the WT cells than the CRBN-/- cells.Western Blot Analysis Cell Line:MOLT-4 cells Concentration:10, 100, 1000, 10000 nM Incubation Time:4 hours Result:Inhibited IFN-γ (10 ng/mL)-stimulated STAT1 phosphorylation (Y701) without causing degradation of JAK1 or JAK2.

——

——

Others

Other Targets

PROTACs | CDK

——

——

2250025-88-6

931.46

C44H51ClN10O9S

>98% (HPLC)

In Vitro:?DMSO : 200 mg/mL (214.72 mM; Ultrasonic )

O=C1NC(=O)C(N2C(=O)C=3C=CC=C(NCC(=O)NCCOCCOCCN4CCN(C5=CC=C(C=C5)NC6=NC=C(Cl)C(=N6)NC=7C=CC=CC7S(=O)(=O)C(C)C)CC4)C3C2=O)CC1

——

(-20℃)

With Ice Pack

≥ 2 years